Item 7.01. Regulation FD Disclosure.
CareMax, Inc., a Delaware corporation (the “Company”), is furnishing as Exhibit
99.1 to this Current Report on Form 8-K and incorporating herein by reference an
investor presentation, which is being used for the Company’s previously
announced presentation at the 40th Annual J.P. Morgan Healthcare Conference on
January 13, 2022 and which may also be used, in whole or in part, and subject to
modification, at subsequent meetings with investors or analysts.
The information furnished in this Item 7.01 of this Current Report on Form 8-K,
including Exhibit 99.1 hereto, shall not be deemed to be “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific reference in such a
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit Index Exhibit No. Description
99.1 Investor Presentation dated January 13, 2022.
104 Cover Page Interactive Data File (the cover page tags are embedded
within the Inline XBRL document).
© Edgar Online, source Glimpses